KR20230019112A - 암을 포함한 연령-관련 질환을 위한 요법으로서 사용하기 위한 미토콘드리아 유래 펩티드 및 그의 유사체 - Google Patents

암을 포함한 연령-관련 질환을 위한 요법으로서 사용하기 위한 미토콘드리아 유래 펩티드 및 그의 유사체 Download PDF

Info

Publication number
KR20230019112A
KR20230019112A KR1020227043805A KR20227043805A KR20230019112A KR 20230019112 A KR20230019112 A KR 20230019112A KR 1020227043805 A KR1020227043805 A KR 1020227043805A KR 20227043805 A KR20227043805 A KR 20227043805A KR 20230019112 A KR20230019112 A KR 20230019112A
Authority
KR
South Korea
Prior art keywords
leu
arg
gly
ser
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227043805A
Other languages
English (en)
Korean (ko)
Inventor
핀차스 코헨
켈빈 옌
수정 김
Original Assignee
유니버시티 오브 써던 캘리포니아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 써던 캘리포니아 filed Critical 유니버시티 오브 써던 캘리포니아
Publication of KR20230019112A publication Critical patent/KR20230019112A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020227043805A 2020-05-15 2021-05-14 암을 포함한 연령-관련 질환을 위한 요법으로서 사용하기 위한 미토콘드리아 유래 펩티드 및 그의 유사체 Pending KR20230019112A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063025495P 2020-05-15 2020-05-15
US63/025,495 2020-05-15
PCT/US2021/032641 WO2021231988A2 (en) 2020-05-15 2021-05-14 Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer

Publications (1)

Publication Number Publication Date
KR20230019112A true KR20230019112A (ko) 2023-02-07

Family

ID=78525101

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227043805A Pending KR20230019112A (ko) 2020-05-15 2021-05-14 암을 포함한 연령-관련 질환을 위한 요법으로서 사용하기 위한 미토콘드리아 유래 펩티드 및 그의 유사체

Country Status (8)

Country Link
US (1) US12577281B2 (https=)
EP (1) EP4149511B1 (https=)
JP (1) JP2023528220A (https=)
KR (1) KR20230019112A (https=)
CN (1) CN115697373A (https=)
CA (1) CA3181427A1 (https=)
MX (1) MX2022014123A (https=)
WO (1) WO2021231988A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115697373A (zh) 2020-05-15 2023-02-03 南加利福尼亚大学 线粒体衍生肽和其类似物作为包括癌症的年龄相关性疾病的治疗的用途
WO2026021591A1 (zh) * 2024-07-26 2026-01-29 南京安吉生物科技有限公司 一种新型调节能量代谢的微肽mp29及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419553D0 (en) * 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
JP2004520803A (ja) 2000-04-21 2004-07-15 コリクサ コーポレイション 尋常性挫瘡の治療および診断のための組成物および方法
CN101586112B (zh) * 2009-06-19 2011-06-22 中国科学院上海有机化学研究所 诺丝七肽的生物合成基因簇
US20140296139A1 (en) * 2013-03-15 2014-10-02 The Regents Of The University Of California Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
EP3022222A4 (en) * 2013-07-18 2017-06-07 Eutropics Pharmaceuticals, Inc. Differential bh3 mitochondrial profiling
BR112016027911A2 (pt) * 2014-05-28 2017-10-24 Evogene Ltd polinucleotídeos isolados, polipeptídeos e métodos de uso dos mesmos para aumento da tolerância ao estresse abiótico, biomassa e produção da planta
CA3026458A1 (en) * 2016-06-24 2017-12-28 University Of Southern California Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
US11208443B2 (en) * 2017-02-14 2021-12-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. NAF-1 derived peptides and uses thereof
CN115697373A (zh) 2020-05-15 2023-02-03 南加利福尼亚大学 线粒体衍生肽和其类似物作为包括癌症的年龄相关性疾病的治疗的用途

Also Published As

Publication number Publication date
WO2021231988A3 (en) 2022-02-24
WO2021231988A2 (en) 2021-11-18
CN115697373A (zh) 2023-02-03
CA3181427A1 (en) 2021-11-18
US12577281B2 (en) 2026-03-17
EP4149511B1 (en) 2026-03-25
MX2022014123A (es) 2022-12-08
JP2023528220A (ja) 2023-07-04
US20230167161A1 (en) 2023-06-01
EP4149511A2 (en) 2023-03-22
EP4149511A4 (en) 2024-05-22

Similar Documents

Publication Publication Date Title
TWI599367B (zh) Ｈｌａ-ａ*１１０１限制性ｗｔ１胜肽之用途
CN104271147A (zh) 细胞穿膜肽
AU2019352354B2 (en) Prophylactic or therapeutic drug for benign tumor
JP2022542167A (ja) Ｃ／ＥＢＰアルファｓａＲＮＡを使用する組成物および方法
EP4149511B1 (en) Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer
WO2021037160A1 (zh) 肿瘤酶响应型重组焦亡蛋白递药系统及其抗肿瘤用途
CN109206482B (zh) 一种抑制消化道炎症的海藻源短肽及其应用
EP1991246A2 (en) Treatment of development-related disorders
KR20190020693A (ko) 당뇨병, 비만, 및 이의 관련 질환 및 합병증들을 위한 치료제로서의 mentsh 유사체
CN108619494B (zh) 促黑激素重组毒素在制备治疗结肠癌药物中的应用
HK40085747A (en) Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer
CN104511028B (zh) Klf9基因在抑制肝癌中的应用
WO2000069910A1 (en) Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity
EP4029515A1 (en) Anti-infection effects of hnrnpa2b1 and use thereof
US10738095B2 (en) Engineered CCL20 locked dimer polypeptide
CN103966237A (zh) 日本血吸虫Wnt5基因、蛋白及应用
KR102708616B1 (ko) 신규 항암 펩타이드 및 이의 용도
US11571462B2 (en) Engineered CCL20 locked dimer polypeptide
CN105348380A (zh) 犬成纤维细胞生长因子21及其在治疗犬内分泌疾病中的用途
CN101017166A (zh) 人rtn4b蛋白在制备抗肿瘤药物中的应用
CN108727484A (zh) 人血清淀粉样蛋白a1功能性短肽及其制备方法和应用
EP3080296B1 (en) A method of predicting a response to an anti-tumor treatment
HK40051038A (en) Prophylactic or therapeutic drug for benign tumor
Hernández Ramírez The role of the aryl hydrocarbon receptor interacting protein (AIP) in pituitary tumorigenesis: A proteomic approach for explaining the clinical behaviour of AIP mutation-associated pituitary adenomas

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20221214

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240513

Comment text: Request for Examination of Application